Przejdź do komentarzy
Przejdź do komentarzy

Endocrine disruptor assessment list

Endocrine disruptor assessment list

ECHA’s endocrine disruptor (ED) assessment list includes the substances undergoing an ED assessment under REACH or the Biocidal Products Regulation that have been brought for discussion to ECHA’s ED Expert Group

Explanatory note

For REACH substances, inclusion in the list means that an informal hazard assessment for endocrine-disrupting properties either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing or evaluating Member State (submitter), the outcome and the suggested follow-up for the assessment, and the date of the latest update to the list entry.

Other process details and hazard assessment outcome documents are also available and can be accessed through the ‘Details’ icon.

One possible outcome of such an assessment is that a substance is considered not to have ED properties.

If the outcome is that the substance is considered to have ED properties, confirmation through the formal risk management and decision-making processes under REACH/BPR is needed before any regulatory action can be taken due to these properties.

The intentions of authorities to submit a dossier to the formal REACH and CLP processes are notified through the Registry of Intentions. All biocidal active substances have to undergo a formal ED assessment. You can see the status of biocides assessments on the Biocidal Active Substances page.

Disclaimer

The information and views set out in the ED assessment list and in the hazard assessment outcome documents are those of the evaluating authority and do not necessarily reflect the position or opinion of the other Member States or ECHA. Neither ECHA nor the evaluating authority nor any person acting on either of their behalves may be held liable for the use, which may be made of the information contained therein. Statements made or information contained in the documents are without prejudice to any formal regulatory activities that ECHA or the Member States may initiate at a later stage. ED assessments and their outcomes are compiled on the basis of information available by the date of the publication of the document.

Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbondioxide

EC / List no: 289-699-3 CAS no: 89997-63-7
Concern
Endocrine disruption
Status
Under development
Outcome
Under development
Follow-up
No suggestion yet
Date of intention
Date of hazard assessment
Hazard assessment outcome document
Remarks
Biocidal active substance
Authority
Spain
Submitter organisation
Ministry of Agriculture, Food and Environment
Submitter email
Submitter phone
Submitter address
Co-submitter(s)
Latest update
30/09/2019

Categories Display


Route: .live1